BioCentury
ARTICLE | Company News

Astex, AstraZeneca drug discovery deal

March 3, 2003 8:00 AM UTC

Astex (LSE:ASX) will screen its small molecule inhibitors against a target from AstraZeneca (LSE:AZN; AZN) that may be involved in Alzheimer's disease. ASX will use its structural screening methods, h...